Which Scan should I have – Navigating the Medical Imaging Maze

Each week in my team consultation practice with specialist GP Dr Bruce Whelan; we hear grave concerns from patients about the radiation risks from diagnostic scans. Unfortunately many cancer patients say no to two imperative diagnostics tools; biopsies and scanning procedures.

Each week in my team consultation practice with specialist GP Dr Bruce Whelan; we hear grave concerns from patients about the radiation risks from diagnostic scans. Unfortunately many cancer patients say no to two imperative diagnostics tools; biopsies and scanning procedures. Usually this is a result of consulting the doctor who never sees a patient and offers a one size fits all approach – yes it’s Dr Google! It is true that medical scans are a source of radiation – however the Health intelligence australiabenefits of knowing as much as possible about your cancer and where it might be located in your body far outweigh the risks. Death from Cancer is not such a great option either I tell my clients.

This is why I interviewed Dr Nevil Chimon on Navigating the Cancer Maze internet radio Select this link to listen

Dr Nevil Chimon researches and develops radio tracers for medical imaging. The science, processes & advances of imaging techniques, & the radio-pharmaceuticals that magically make our inner parts visible to doctors for more accurate diagnosis; is the topic for today’s Navigating the Cancer Maze. Dr Nevil Chimon shares his passion and invaluable information for cancer patients about the different types of cancer & the best medical imaging to assist diagnosis. This is information that you need to know! All patients become intimately involved with the process of cancer imaging, & the relationship often lasts for 5 or more years.

BIOGRAPHY:  Dr Chimon is a medical science graduate of UCLAN, BSc (Hons), Manchester University, MSc & NUS, PhD, with Post-Doctoral training in Molecular Imaging & Radiochemistry completed at the Paterson Institute for Cancer Research & Wolfson Molecular Imaging Centre, UK. Nevil has over 10 years of experience within the pharmaceuticals industry. Holding positions of increasing responsibility within MNCs and SMEs has provided him with broad exposure to projects involving drug discovery & imaging diseases, including cancer & dementia. Strategically, he recognizes an opportunity exists to leverage on molecular imaging technology to both accelerate drug discovery and improve the healthcare of patients by using PET-CT and PET-MRI multi-modality imaging.

Dr Nevil Chimon BSc (Hons), MSc and NUS, PhD,
Dr Nevil Chimon BSc (Hons), MSc and NUS, PhD,

During his 7-years based in Singapore, Dr Chimon has established the first Preclinical CRO imaging facility, obtained GMP licensing for the RadLink cyclotron facility, performed the first clinical trial with a proprietary radio-tracer for Bayer Pharmaceuticals, & manufactured new tracers to detect cancer. To Listen to my interview with Dr Nevil Chimon: CLICK HERE

As a Cancer Patient – You need to Know your imaging options so you make an informed choice:

Different imaging methods use different technology and provide different types of images. This means they have different benefits for showing what is happening inside the body (e.g. for showing bone, soft tissue or tumours). Imaging methods also have different potential advantages and disadvantages, including exposure to radiation.

Here are just a few of the New Scanning devices and procedures  you need to know about:
Prostate CancerPSMA (Prostate Specific Membrane Antigen) PET-CT – A PSMA study, also called a ProstaScint® scan, is an imaging test to locate and determine the extent of prostate cancer. PSMA studies are performed on newly diagnosed prostate cancer patients to determine if the disease has spread to pelvic lymph nodes. The study is also performed on patients who have had their prostate gland removed (prostatectomy) and have an increase in prostate-specific antigen (PSA) blood levels.

The study involves a special molecule called a monoclonal antibody developed in a laboratory and designed to bind to the prostate-specific membrane antigen on cancer cells. This antibody is paired with a radioactive material called Indium-111 that can be detected by a gamma camera. When injected into the patient’s bloodstream, the radioactive antibody travels and attaches to cancer cells. The gamma camera then produces three-dimensional images of the tumor and its location inside the body. This study is performed over as many as three days. On the first day, the patient first receives an intravenous (IV) injection of the radioactive antibody. Imaging is performed in two sessions, separated by 24 or more hours. Each imaging session will last between two and four hours. The camera rotates around the patient, who remains still.

  • Molecular imaging and prostate cancer? Molecular imaging is used to:
    stage treatment: by determining the exact location of a tumor, the extent or stage of the disease and whether the cancer has spread in the body and plan treatment by selecting the most effective therapy based on the unique molecular properties of the disease and of the patient’s genetic makeup
  • Choline C-11 PET scan is an imaging test used to help detect sites of prostate cancer that have returned despite treatment (recurrent prostate cancer). It may be used when other imaging has not been helpful. Choline C-11 PET scan is a positron emission tomography (PET) scan that uses a special chemical tracer called Choline C-11 Injection.
  • Valuable links:
    11E_The use of Choline PET_CT in prostate cancer imaging_Tara Barwick
    SCANNING FOR PROSTATE CANCER

    Targeted therapies offer new options for prostate cancer treatment
  • Breast Cancer:  MRI:  Some women, particularly those under the age of 50 and who are at high risk of developing breast cancer due to a strong family history or a genetic mutation, are encouraged to undergo annual breast Magnetic Resonance Imaging (MRI) as part of their regular screening routine. MRI is sometimes a more effective screening tool for younger women, especially those with dense breasts. MRI scans are very expensive — up to $700 AUD per scan. There is a Medicare rebate for women at high risk of developing breast cancer.
  • Mammograms A mammogram is an X-ray of the breast and is the most common form of breast imaging. There are two types of mammogram — screening and diagnostic.
    Screening mammograms: Screening mammograms are used for women who do not have any symptoms of breast cancer and who have not had breast cancer in the past. If you are aged 40 or over, have never been diagnosed with breast cancer and currently have no symptoms of breast cancer, you can be screened free of charge at a BreastScreen Australia clinic.
    Diagnostic Mammograms Diagnostic mammograms are recommended for women who have a previous history of breast cancer or who are at high risk of developing breast cancer. Several X-rays are taken in order to obtain views of the breast/s from different angles. You will need a referral from a doctor for a diagnostic mammogram.
  • More info at http://www.bcna.org.au/living-breast-cancer/follow-care/breast-imaging

Diagnosing NETS (neuroendocrine tumours).

  • Ga68 DOTATE is a somatostatin receptor agent used in the imaging of well-differentiated neuroendocrine tumours. For poorly differentiated neuroendocrine tumours; standard F18 FDG-PET remains the imaging of choice for diagnosis. Dr Nevil Chimon discusses NET imaging options and the latest developments in my interview with him on Voice America.

Different types of imaging

  • X-rays (plain radiography) – Uses X-rays to show images of bones, tumours and other dense matter
  • Advantages: Quick, non-invasive and painless
    Can help diagnose various diseases and injuries, including broken bones, cancer and infections
    Disadvantages: Very small increased risk of cancer in future from exposure to ionising radiation (x-rays). Risk is greater for children
  • Computed tomography (CT scans) Uses multiple X-rays to produce cross-sectional layers that show detailed images inside the body, including bones, organs, tissues, and tumours.
    Advantages*Quick and painless
    *Can help diagnose and guide treatment for a wider range of conditions than plain X-rays
    *Can detect or exclude the presence of more serious problems
    *Can be used to check if a previously treated disease has recurred
    Disadvantages*Small increased risk of cancer in future from exposure to ionising radiation (X-rays). Risk is greater for children
    *Uses higher doses of radiation, so the risks (while still small) are in general greater than other imaging types
    *Injection of a contrast medium (dye) can cause kidney problems or result in allergic or injection-site reactions in some people -Some procedures require anaesthesia.
  • Nuclear medicine imaging including positron-emission tomography (PET) Involves injecting, inhaling or swallowing a radioactive ‘tracer’. The gamma-rays emitted by this material are used by the scanner to show images of bones and organs:
    Advantages*Usually painless
    *Can help diagnose, treat, or predict the outcome for a wide range of conditions
    *Unlike most other imaging types, can show how different parts of the body are working and can detect problems much earlier
    *Can check how far a cancer has spread and how well treatment is working
    *Involves exposure to ionising radiation (gamma-rays)
    Disadvantages A PET scan can take 3 to 4 hrs from arrival to departure
  • *Radioactive material may cause allergic or injection-site reactions in some people
    *PET scanners cause some people to feel claustrophobic, which may mean sedation is required
  • Magnetic resonance imaging (MRI) Uses magnetic fields and radio waves to show detailed images of organs, soft tissues, bones, ligaments and cartilage
  • Advantages*Usually non-invasive and painless
    *Uses no ionising radiation
    *Can help diagnose and guide treatment for a wide range of conditions
    *Can provide similar information to CT in some types of investigations
    Disadvantages*Can be a lengthy and noisy procedure
    *Slight movement can ruin the image, requiring retesting
    *Can make some people feel claustrophobic
    *Sedation or anaesthesia may be required for young children or others who can’t remain still
    *Injection of a contrast medium (dye) if needed can cause kidney problems or result in allergic or injection-site reactions in some people
    Can’t be undertaken in some situations (e.g. when a heart pacemaker is present)
  • Ultrasound Uses high-frequency sound waves to produce moving images onto a screen of the inside of the body, including organs, soft tissues and bones
  • Advantages*Usually non-invasive, safe and relatively painless
    *Uses no ionising radiation
    *Does not usually require injection of a contrast medium (dye)
    *Can help diagnose a range of conditions in different parts of the body, such as the abdomen, pelvis, blood vessels, breast, kidneys, muscles, bones and joints
    Disadvantages*Quality and interpretation of the image highly depends on the skill of the person doing the scan
    *Other factors can affect image quality, including the presence of air and calcified areas in the body (e.g. bones, plaques and hardened arteries), and a person’s body size
    *Use of a special probe (e.g. for the oesophagus, rectum or vagina) is required in some ultrasounds
    *Special preparations may be required before a procedure (e.g. fasting or a full bladder)
  • Bone scan? A bone scan is a diagnostic imaging test used to determine whether cancer has spread to the skeleton. A tiny amount of radio-tracer is injected into the patient’s bloodstream and accumulates predominantly in the bones where it can be detected by a specialized imaging device called a gamma camera. The resulting two-dimensional or three-dimensional images can reveal various processes such as bony fractures, infection or inflammation or the likely presence of cancer cells.

Select the following URL to learn about the impact of radiation from Medical Scanning:
http://www.radiologyinfo.org/en/safety/?pg=sfty_xray

Medical imaging and Theranostics (developing molecular diagnostic tests in tandem with targeted therapeutics) are medical sciences that are moving forward at a rapid pace.  Ask your oncologist/radiologist for the latest information about new  scanning machines and techniques for your particular type of tumour.

We see many patients who have foregone critical diagnostic scans due to fears about radiation from scanning devices; mainly after reading  poorly researched information on Dr Google. All cancer situations need proper diagnosing and monitoring. Most medical scans carry a small long term risk from radiation exposure – but to not know about a burgeoning cancer is a far greater risk to life and longevity.

If you need assistance and case management – you can consult with myself and specialist GP Dr Bruce Whelan in a team consultation at our Gold Coast, Qld Practice. I am also available for Skype consultations for distance Clients – We are able to offer world-wide referrals. To Contact myself and Dr Whelan:  Email institute@gracegawler.com

Until next Time….

Grace

Groundbreaking Cancer Immunotherapy Grace Gawler interviews Dr Horst Lindhoffer Munich

On today’s edition of Navigating the Cancer Maze, Grace Gawler interviews Dr Horst Lindhoffer PhD about one of the most innovative and exciting cancer immunotherapy treatment breakthroughs in many years. Visit germancancertreatments.com for more information.

On Navigating the Cancer Maze – Cancer Immunotherapy – Ground-breaking treatment in Cancer Medicine Grace Gawler -August 2, 2013

 “Destroying cancer stem cells means fighting cancer at its roots”, says Horst Lindhofer, CEO of TRION Pharma. “Catumaxomab’s efficacy against this particularly aggressive and resistant population of cancer cells further supports its therapeutic potential for the treatment of EpCAM-positive carcinomas.”

On today’s edition of Navigating the Cancer Maze, I interview Dr Horst Lindhoffer PhD about one of the most innovative and exciting cancer treatment breakthroughs in many years. We know that The human immune system is usually quite effective at identifying and eliminating abnormal cells.

dr horst lindhofer
Dr Horst Lindhofer

 Cancer cells, however, can form tumors and spread throughout the body. Although chaotic in their behavior, cancer cells operate with high level intelligence to escape detection by our immune system’s control mechanisms. Often misunderstood, this is a fundamental principle in understanding how cancer cells behave and how immune recognition can be assisted. The new breakthrough cancer treatments capitalize on that information. It has been a long-standing vision of physicians and scientists to develop a treatment that can put the immune system back on track. TRION has achieved the goal with its trifunctional Triomab® antibodies. Listen to learn more or contact grace@germancancertreatments.com for further details.

Listen to this interview at:
http://www.voiceamerica.com/episode/72038/cancer-immunotherapy-ground-breaking-treatment-in-cancer-medicine
Catumaxomab (Removab®) is presently the only approved therapeutic antibody targeting EpCAM, a surface antigen that is widely expressed in the most frequent forms of human cancer. On April 20th this year, Removab® received EU approval for the intraperitoneal treatment of malignant ascites in patients with EpCAM-positive carcinomas. Removab® is the first product world-wide to receive a regulatory approval for this indication. With its trifunctional mode of action, Removab® represents a new generation of antibodies using the body’s own immune system to help fight the tumor cells.

For more information visit www.germancancertreatments.com Enquiries: To discover more about Horst Lindhoffer’s work with Trifunctional antibodies  – please email grace@germancancertreatments.com

EpCAM: EpCAM or epithelial cell adhesion molecule is a pan-epithelial differentiation antigen that is expressed on almost all carcinomas, such as breast, lung, colorectal, gastric, prostate and ovarian cancer. Catumaxomab (Removab®) is the only approved anti-EpCAM antibody available.

Triomab®: Trifunctional antibodies : Triomab® antibodies bind to cancer-specific surface antigens and recruit both T cells as well as accessory cells, such as macrophages, dendritic cells and natural killer cells, to the tumor site. As a result, they provide for a new quality of cancer cell killing, activating both arms of the immune system – the adaptive one with cytotoxic T cells as effectors and the innate one including accessory effector cells.

dendritic cell image
dendritic cell image

Triomab® antibodies are therefore very effective in destroying cancer cells and show a therapeutic effect at very low doses. Triomab® antibodies are a development of TRION Pharma GmbH Catumaxomab was invented by TRION Pharma and has been developed with Fresenius Biotech.

Trifunctional Antibody Catumaxomab Triggers Vaccination Effect Against Cancer: On June 06, 2011 Munich, Germany TRION Pharma GmbH released and announced new information – the results from two different studies demonstrating catumaxomab’s capacity to activate the immune system in a way that can otherwise only be achieved through vaccination.  Continue reading “Groundbreaking Cancer Immunotherapy Grace Gawler interviews Dr Horst Lindhoffer Munich”

Grace Gawler Institute and German Cancer Treatments Prostate Cancer News

Recent research at the Grace Gawler Institute – enabled by QR National and Dr Jacob Clinic Germany has allowed us to create for the first time, a unique cross section of options and information regarding prostate cancer prevention and management including groundbreaking diagnostic and treatment methods.

Prostate Mates the Grace Gawler Institute and German cancer treatmentsThis year the Grace Gawler Institute has focused on innovative solutions for Australian men diagnosed with prostate cancer as well as studying strategies for taking preventive action.
Did you know there are 20,000 men diagnosed with prostate cancer in Australia each year….there are 12,000 new cases of breast cancer! There is an imperative for greater awareness, information.
During May this year we took our unique Prostate Mates program on the road to the mining town of Mt Isa. Now it will soon be launched on the Gold Coast. We have essentialised treatments and approaches of excellence based on our research in Australia, Asia and Germany.  If you know someone who has prostate cancer and lives in northern NSW or Qld – then please let them know about our seminar:

Boost your Prostate Cancer Recovery – 10 powerful steps
Innovative Prostate Mates Program featuring expert information you won’t find elsewhere!

Sunday 24th June – 2012 – Pre-booking essential

Time: 10am – 3pm includes lunch

Cost: $40 (program subsidised by QR National)

Venue: Paradise Point – North Gold Coast (map emailed on receipt of registration)

Enquiries:  director@gracegawler.com  – Call the Grace Gawler Institute on 07 5577 2997

Recent research at the Grace Gawler Institute – enabled by QR National and Dr Jacob Clinic Germany has allowed us to create for the first time, a unique cross section of options and information regarding prostate cancer prevention and management including groundbreaking diagnostic and treatment methods.

Program explores:

  • Early detection & breakthrough diagnostics
  • Nutrition – diet & supplements
  • Treatment Options – including breakthrough therapies
  • Value of clear communication – Let’s talk about it
  • Exercise as a therapy
  • Relationship issues and prostate cancer
  • Taking charge of your recovery
  • Dealing with advanced prostate cancer – side effects
  • Life quality when considering treatments
  • What is on offer at German and Dutch clinics

All you need to know to make wise choices about Prostate cancer. Take away a PRO-State action plan to discuss with your doctor.

Please visit www.prostatemates.com  to register & pay to attend this seminar or for more information.

By forwarding this email to friends you can assist in our Australian campaign for prostate health awareness and education for men.

SW1domains.com for all hosting
www.sw1domains.com for all your hosting needs

Pesticides in and on foods- we are what we eat! Grace Gawler

The following is an except from a brilliantly prepared blog post. For your health’s sake, I highly recommend you check it out – you may be suprised!
Pesticides
“Most of us both want to know … and don’t want to know… what is on and in what we eat. The aim of the blog (link provided) is to give you an overview of typical pesticide residues in fruits and vegetables. See this guide more as a generalized overview than exact facts. The figures are taken from samples on the German market between 2005 and 2010 and is possibly not applicable on every market in the world. But it gives a hint.” Major source is Pestizidreport Nordrhein-Westfalen.

http://www.ekopolitan.com/guides/guide-pesticide-residues
I hope you find this as useful as I did – Remember if you are juicing vegetables and fruits – it is so important to use organically grown produce. The following section on carrots taken from the blog, will give you an idea why organically grown produce is so important……
Carrots

  Substance Found in (%) of the samples
1. Linuron 13%
2. Boscalid; Nicobifen 12%
3. Tebuconazol 10%
4. Chlorfenvinphos 6%
5. Pyraclostrobin 2%
6. Omethoat 1%
7. Dimethoat 1%
8. Azoxystrobin 1%
9. Difenoconazol 1%
10. Iprodion; Glycophen 1%

A total of 389 samples of which 128 were sold as organic. Of all samples, 27 % contained pesticide residues, 73 % did not. 2 % of the organic samples contained pesticides.
Grace Gawler